General Hospital Maria Middelares
Ghent, Belgium
NCT Number: NCT02050490
This study investigates whether the implementation of a symptom diary for reporting and communicating chemotherapy-related symptoms improves symptom care and decreases symptom burden in adult patients treated with chemotherapy.
The hypothesis is studied using a before-and-after design. First, symptom care and symptom burden will be observed in a sample of patients not being offered a symptom diary. Next, the symptom diary will be implemented at the participating hospital and symptom care and symptom burden will now be observed in a new sample of chemotherapy patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ghent, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: T1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1), T4 (cycle 5, day 1)
for each of 9 symptoms: how distressing was the symptom perceived by the patient? (ordinal variable)
Time frame: T1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1), T4 (cycle 5, day 1)
for each of 9 symptoms: how severe was the symptom? (ordinal variable)
Time frame: T1 (cycle 1, day 1), T2 (cycle 2, day 1), T3 (cycle 3, day 1)
binary variable expressing whether the patient has received care (either medication or advice) to help with the symptom
Universitaire Ziekenhuizen KU Leuven
Other
Effect of the Implementation of a Symptom Diary on the Symptom Care Received and the Symptom Burden Experienced by Adult Cancer Patients Treated With Chemotherapy: A Before-and-after-study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06439121
Nausea, Nausea, Postoperative
Yenimahalle, Ankara, Turkey (Türkiye)
View Trial DetailsNCT05315999
Advanced Cancer, Nausea
Freiburg im Breisgau, Germany
View Trial DetailsNCT06040411
Anxiety Disorders, Anxiety State
Yenişehir, Mersin, Turkey (Türkiye)
View Trial DetailsNCT03657810
Nausea, Neurologic Manifestations
Phoenix, Arizona, United States
View Trial Details